Desonate

Desonate is a brand name of desonide topical, approved by the FDA in the following formulation(s):

DESONATE (desonide - gel; topical)

• 
  Manufacturer: INTENDIS
  
  Approval date: October 20, 2006
  
  Strength(s): 0.05% ^[RLD]

Has a generic version of Desonate been approved?

No. There is currently no therapeutically equivalent version of Desonate available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Desonate. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Topical low-viscosity gel composition
  Patent 6,387,383
  Issued: May 14, 2002
  Inventor(s): Gordon J.; Dow & Robert W.; Lathrop & Debra A.; Dow
  Assignee(s): Dow Pharmaceutical Sciences
  A composition is provided that has a viscosity of less than about 15,000 cP and a pH of about 3.0 to 9.0 for treating a skin disorder in a human subject. The composition consists essentially of (a) a therapeutically-effective amount of at least one compound useful for treating such disorder, (b) a pharmaceutically-acceptable, lightly cross-linked polyacrylic acid polymer compatible with the compound, (c) optionally a water miscible solvent, (d) optionally a preservative, (e) optionally an oil phase component and suitable surfactant, and (f) water. The composition is useful for treating an inflammatory skin disorder, acne, or rosacea. The low viscosity composition has an advantage of being administered more accurately when combined with a container that administers the composition as drops.
  
  Patent expiration dates:
  
  
  • August 3, 2020
    
    ✓ 
    Patent use: DESONATE GEL IS INDICATED FOR THE TREATMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN PATIENTS 3 MONTHS OF AGE AND OLDER
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

See also...

• Desonate Consumer Information (Drugs.com)
• Desonate Gel Consumer Information (Wolters Kluwer)
• Desonate Consumer Information (Cerner Multum)
• Desonate Advanced Consumer Information (Micromedex)
• Desonide Cream Consumer Information (Wolters Kluwer)
• Desonide Foam Consumer Information (Wolters Kluwer)
• Desonide Gel Consumer Information (Wolters Kluwer)
• Desonide Lotion Consumer Information (Wolters Kluwer)
• Desonide topical Consumer Information (Cerner Multum)
• Pms-Desonide Advanced Consumer Information (Micromedex)
• Desonide Topical application Advanced Consumer Information (Micromedex)
• Desonide AHFS DI Monographs (ASHP)